Wissam Abouzgheib, MD, chief of pulmonary medicine at Cooper University Health Care, is participating in a clinical study investigating a new device treatment for chronic obstructive pulmonary disease (COPD) with chronic bronchitis. Cooper is the 20th site nationally participating in the study.
COPD is a long-term, progressive, irreversible lung disease that, over time, makes it difficult to breathe. Chronic bronchitis (CB), the largest subset of COPD, is characterized by a chronic productive cough. Read more.

Cooper University Health Care has been recognized by the Office of Disease Prevention and Health Promotion (ODPHP) within the U.S. Department of Health and Human Services (HHS) as a 